CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
CSL Limited announced that its subsidiary, CSL Seqirus, finalized its global collaboration and license agreement with Arcturus Therapeutics Holdings Inc (“Arcturus Therapeutics”;…
Read More...
Read More...
